Equities

Petmed Express Inc

Petmed Express Inc

Actions
  • Price (EUR)3.25
  • Today's Change-0.023 / -0.70%
  • Shares traded1.00
  • 1 Year change-70.09%
  • Beta--
Data delayed at least 15 minutes, as of Sep 18 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Petmed Express Inc had net income fall from a gain of 5.14m to a loss of 7.46m despite a 9.54% increase in revenues from 256.58m to 281.06m. An increase in the selling, general and administrative costs as a percentage of sales from 23.83% to 28.38% was a component in the falling net income despite rising revenues.
Gross margin27.36%
Net profit margin-0.95%
Operating margin-0.61%
Return on assets-1.53%
Return on equity-2.60%
Return on investment-2.57%
More ▼

Cash flow in USDView more

In 2024, cash reserves at Petmed Express Inc fell by 48.79m. However, the company earned 4.32m from its operations for a Cash Flow Margin of 1.54%. In addition the company used 40.67m on investing activities and also paid 12.44m in financing cash flows.
Cash flow per share0.2202
Price/Cash flow per share16.48
Book value per share4.54
Tangible book value per share2.47
More ▼

Balance sheet in USDView more

Petmed Express Inc uses little or no debt in its capital structure.
Current ratio1.33
Quick ratio0.8937
Total debt/total equity0.00
Total debt/total capital0.00
More ▼

Growth rates in USD

SmartText is unavailable
Div yield(5 year avg)6.30%
Div growth rate (5 year)-10.76%
Payout ratio (TTM)--
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
-312.06
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.